Cipla 2011 Harvard Case Solution & Analysis

Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while placing his company for growth in a changing regulatory landscape.

PUBLICATION DATE: April 12, 2011 PRODUCT #: 511050-PDF-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

Share This